A high-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors

Anticancer Research

Volumn 32, Issue 1, 2012, Pages 147-151

  Lin, Wen Hsing ^a   Jen Shin, Song ^a   Lien, Tzu Wen ^a   Chang, Chun Yu ^a   Wu, Szu Huei ^a   Huang, Yu Wen ^a   Chang, Teng Yuan ^a   Fang, Ming Yu ^a   Yen, Kuei Jung ^a   Chen, Chun Hwa ^a   Chu, Chang Ying ^a   Hsieh, Hsing Pang ^a   Chen, Yi Rong ^a   Chao, Yu Sheng ^a   Hsu, John T A ^a,b  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

EGFR; HTS; Non small cell lung cancer (NSCLC); TKI

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GEFITINIB; MUTANT PROTEIN; PROTEIN L858R; PROTEIN T790M; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SCREENING; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; EPIDERMAL GROWTH FACTOR; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LUNG NEOPLASMS; MUTATION; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 84862937281     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tiseo M, Loprevite M and Ardizzoni A: Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer. Curr Med Chem Anticancer Agents 4: 139-148, 2004. (Pubitemid 38404689)
2. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M and Varmus H: EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101: 13306-13311, 2004. (Pubitemid 39209661)
3. Mitsudomi T, Kosaka T and Yatabe Y: Biological and clinical implications of EGFR mutations in lung cancer. Int J Clin Oncol 11: 190-198, 2006. (Pubitemid 44087117)
4. Lin WH, Song JS, Chang TY, Chang CY, Fu YN, Yeh CL, Wu SH, Huang YW, Fang MY, Lien TW, Hsieh HP, Chao YS, Huang SF, Tsai SF, Wang LM, Hsu JT and Chen YR: A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors. Anal Biochem 377: 89-94, 2008.
5. Wu CH, Coumar MS, Chu CY, Lin WH, Chen YR, Chen CT, Shiao HY, Rafi S, Wang SY, Hsu H, Chen CH, Chang CY, Chang TY, Lien TW, Fang MY, Yeh KC, Chen CP, Yeh TK, Hsieh SH, Hsu JT, Liao CC, Chao YS and Hsieh HP: Design and synthesis of tetrahydropyridothieno[2,3-D]pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and Michael acceptor group for maximal potency. J Med Chem 53: 7316-7326, 2010.
6. Chen YR, Fu YN, Lin CH, Yang ST, Hu SF, Chen YT, Tsai SF and Huang SF: Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants. Oncogene 25: 1205-1215, 2006.
7. Fu YN, Yeh CL, Cheng HH, Yang CH, Tsai SF, Huang SF and Chen YR: EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy. Oncogene 27: 957-965, 2008. (Pubitemid 351225379)
8. Zhang JH, Chung TD and Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high-throughput screening assays. J Biomol Screen 4: 67-73, 1999. (Pubitemid 29278954)
9. Partik G, Hochegger K, Schorkhuber M and Marian B: Inhibition of epidermal-growth-factor-receptor-dependent signalling by tyrphostins A25 and AG1478 blocks growth and induces apoptosis in colorectal tumor cells in vitro. J Cancer Res Clin Oncol 125: 379-388, 1999. (Pubitemid 29287495)
10. Kobayashi S, Ji H, Yuza Y, Meyerson M, Wong KK, Tenen DG and Halmos B: An alternative inhibitor overcomes resistance caused by a mutation of the epidermal growth factor receptor. Cancer Res 65: 7096-7101, 2005. (Pubitemid 41161238)
11. Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH and Parsons SJ: c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274: 8335-8343, 1999.
12. Kloth MT, Laughlin KK, Biscardi JS, Boerner JL, Parsons SJ and Silva CM: STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J Biol Chem 278: 1671-1679, 2003. (Pubitemid 36801399)